Global Imatinib Mesylate API Supply, Demand and Key Producers, 2023-2029
The global Imatinib Mesylate API market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Imatinib Mesylate API production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Imatinib Mesylate API, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Imatinib Mesylate API that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Imatinib Mesylate API total production and demand, 2018-2029, (Tons)
Global Imatinib Mesylate API total production value, 2018-2029, (USD Million)
Global Imatinib Mesylate API production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global Imatinib Mesylate API consumption by region & country, CAGR, 2018-2029 & (Tons)
U.S. VS China: Imatinib Mesylate API domestic production, consumption, key domestic manufacturers and share
Global Imatinib Mesylate API production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Tons)
Global Imatinib Mesylate API production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global Imatinib Mesylate API production by Application production, value, CAGR, 2018-2029, (USD Million) & (Tons)
This reports profiles key players in the global Imatinib Mesylate API market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aurobindo Pharma Ltd, Formosa Laboratories Inc, Cadila Healthcare Ltd, Laurus Labs Ltd, Msn Laboratories Private Ltd, Intas Pharmaceuticals Ltd, Zydus Lifesciences Ltd, Hetero Labs Ltd and Shilpa Pharma Lifesciences Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Imatinib Mesylate API market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Imatinib Mesylate API Market, By Region:
1. How big is the global Imatinib Mesylate API market?
2. What is the demand of the global Imatinib Mesylate API market?
3. What is the year over year growth of the global Imatinib Mesylate API market?
4. What is the production and production value of the global Imatinib Mesylate API market?
5. Who are the key producers in the global Imatinib Mesylate API market?
6. What are the growth factors driving the market demand?
This report studies the global Imatinib Mesylate API production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Imatinib Mesylate API, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Imatinib Mesylate API that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Imatinib Mesylate API total production and demand, 2018-2029, (Tons)
Global Imatinib Mesylate API total production value, 2018-2029, (USD Million)
Global Imatinib Mesylate API production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global Imatinib Mesylate API consumption by region & country, CAGR, 2018-2029 & (Tons)
U.S. VS China: Imatinib Mesylate API domestic production, consumption, key domestic manufacturers and share
Global Imatinib Mesylate API production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Tons)
Global Imatinib Mesylate API production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global Imatinib Mesylate API production by Application production, value, CAGR, 2018-2029, (USD Million) & (Tons)
This reports profiles key players in the global Imatinib Mesylate API market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aurobindo Pharma Ltd, Formosa Laboratories Inc, Cadila Healthcare Ltd, Laurus Labs Ltd, Msn Laboratories Private Ltd, Intas Pharmaceuticals Ltd, Zydus Lifesciences Ltd, Hetero Labs Ltd and Shilpa Pharma Lifesciences Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Imatinib Mesylate API market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Imatinib Mesylate API Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Purity?99%
- Purity<99%
- Tablet
- Capsule
- Aurobindo Pharma Ltd
- Formosa Laboratories Inc
- Cadila Healthcare Ltd
- Laurus Labs Ltd
- Msn Laboratories Private Ltd
- Intas Pharmaceuticals Ltd
- Zydus Lifesciences Ltd
- Hetero Labs Ltd
- Shilpa Pharma Lifesciences Ltd
- Teva Pharmaceutical Industries Ltd
- Cipla Ltd
- Acebright India Pharma Private Ltd
- Fis Fabbrica Italiana Sintetici Spa
- Dr Reddys Laboratories Ltd
- Natco Pharma Ltd
- Sun Pharmaceutical Industries Ltd
- Reliance Life Sciences Pvt Ltd
- Zhejiang Jiuzhou Pharmaceutical Co Ltd
- Tai Heng Industry Group Co Ltd
- Shandong Anxin Pharmaceutical Co Ltd
1. How big is the global Imatinib Mesylate API market?
2. What is the demand of the global Imatinib Mesylate API market?
3. What is the year over year growth of the global Imatinib Mesylate API market?
4. What is the production and production value of the global Imatinib Mesylate API market?
5. Who are the key producers in the global Imatinib Mesylate API market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Imatinib Mesylate API Introduction
1.2 World Imatinib Mesylate API Supply & Forecast
1.2.1 World Imatinib Mesylate API Production Value (2018 & 2022 & 2029)
1.2.2 World Imatinib Mesylate API Production (2018-2029)
1.2.3 World Imatinib Mesylate API Pricing Trends (2018-2029)
1.3 World Imatinib Mesylate API Production by Region (Based on Production Site)
1.3.1 World Imatinib Mesylate API Production Value by Region (2018-2029)
1.3.2 World Imatinib Mesylate API Production by Region (2018-2029)
1.3.3 World Imatinib Mesylate API Average Price by Region (2018-2029)
1.3.4 North America Imatinib Mesylate API Production (2018-2029)
1.3.5 Europe Imatinib Mesylate API Production (2018-2029)
1.3.6 China Imatinib Mesylate API Production (2018-2029)
1.3.7 Japan Imatinib Mesylate API Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Imatinib Mesylate API Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Imatinib Mesylate API Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Imatinib Mesylate API Demand (2018-2029)
2.2 World Imatinib Mesylate API Consumption by Region
2.2.1 World Imatinib Mesylate API Consumption by Region (2018-2023)
2.2.2 World Imatinib Mesylate API Consumption Forecast by Region (2024-2029)
2.3 United States Imatinib Mesylate API Consumption (2018-2029)
2.4 China Imatinib Mesylate API Consumption (2018-2029)
2.5 Europe Imatinib Mesylate API Consumption (2018-2029)
2.6 Japan Imatinib Mesylate API Consumption (2018-2029)
2.7 South Korea Imatinib Mesylate API Consumption (2018-2029)
2.8 ASEAN Imatinib Mesylate API Consumption (2018-2029)
2.9 India Imatinib Mesylate API Consumption (2018-2029)
3 WORLD IMATINIB MESYLATE API MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Imatinib Mesylate API Production Value by Manufacturer (2018-2023)
3.2 World Imatinib Mesylate API Production by Manufacturer (2018-2023)
3.3 World Imatinib Mesylate API Average Price by Manufacturer (2018-2023)
3.4 Imatinib Mesylate API Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Imatinib Mesylate API Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Imatinib Mesylate API in 2022
3.5.3 Global Concentration Ratios (CR8) for Imatinib Mesylate API in 2022
3.6 Imatinib Mesylate API Market: Overall Company Footprint Analysis
3.6.1 Imatinib Mesylate API Market: Region Footprint
3.6.2 Imatinib Mesylate API Market: Company Product Type Footprint
3.6.3 Imatinib Mesylate API Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Imatinib Mesylate API Production Value Comparison
4.1.1 United States VS China: Imatinib Mesylate API Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Imatinib Mesylate API Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Imatinib Mesylate API Production Comparison
4.2.1 United States VS China: Imatinib Mesylate API Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Imatinib Mesylate API Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Imatinib Mesylate API Consumption Comparison
4.3.1 United States VS China: Imatinib Mesylate API Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Imatinib Mesylate API Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Imatinib Mesylate API Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Imatinib Mesylate API Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Imatinib Mesylate API Production Value (2018-2023)
4.4.3 United States Based Manufacturers Imatinib Mesylate API Production (2018-2023)
4.5 China Based Imatinib Mesylate API Manufacturers and Market Share
4.5.1 China Based Imatinib Mesylate API Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Imatinib Mesylate API Production Value (2018-2023)
4.5.3 China Based Manufacturers Imatinib Mesylate API Production (2018-2023)
4.6 Rest of World Based Imatinib Mesylate API Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Imatinib Mesylate API Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Imatinib Mesylate API Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Imatinib Mesylate API Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Imatinib Mesylate API Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Purity?99%
5.2.2 Purity<99%
5.3 Market Segment by Type
5.3.1 World Imatinib Mesylate API Production by Type (2018-2029)
5.3.2 World Imatinib Mesylate API Production Value by Type (2018-2029)
5.3.3 World Imatinib Mesylate API Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Imatinib Mesylate API Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Tablet
6.2.2 Capsule
6.3 Market Segment by Application
6.3.1 World Imatinib Mesylate API Production by Application (2018-2029)
6.3.2 World Imatinib Mesylate API Production Value by Application (2018-2029)
6.3.3 World Imatinib Mesylate API Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Aurobindo Pharma Ltd
7.1.1 Aurobindo Pharma Ltd Details
7.1.2 Aurobindo Pharma Ltd Major Business
7.1.3 Aurobindo Pharma Ltd Imatinib Mesylate API Product and Services
7.1.4 Aurobindo Pharma Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Aurobindo Pharma Ltd Recent Developments/Updates
7.1.6 Aurobindo Pharma Ltd Competitive Strengths & Weaknesses
7.2 Formosa Laboratories Inc
7.2.1 Formosa Laboratories Inc Details
7.2.2 Formosa Laboratories Inc Major Business
7.2.3 Formosa Laboratories Inc Imatinib Mesylate API Product and Services
7.2.4 Formosa Laboratories Inc Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Formosa Laboratories Inc Recent Developments/Updates
7.2.6 Formosa Laboratories Inc Competitive Strengths & Weaknesses
7.3 Cadila Healthcare Ltd
7.3.1 Cadila Healthcare Ltd Details
7.3.2 Cadila Healthcare Ltd Major Business
7.3.3 Cadila Healthcare Ltd Imatinib Mesylate API Product and Services
7.3.4 Cadila Healthcare Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Cadila Healthcare Ltd Recent Developments/Updates
7.3.6 Cadila Healthcare Ltd Competitive Strengths & Weaknesses
7.4 Laurus Labs Ltd
7.4.1 Laurus Labs Ltd Details
7.4.2 Laurus Labs Ltd Major Business
7.4.3 Laurus Labs Ltd Imatinib Mesylate API Product and Services
7.4.4 Laurus Labs Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Laurus Labs Ltd Recent Developments/Updates
7.4.6 Laurus Labs Ltd Competitive Strengths & Weaknesses
7.5 Msn Laboratories Private Ltd
7.5.1 Msn Laboratories Private Ltd Details
7.5.2 Msn Laboratories Private Ltd Major Business
7.5.3 Msn Laboratories Private Ltd Imatinib Mesylate API Product and Services
7.5.4 Msn Laboratories Private Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Msn Laboratories Private Ltd Recent Developments/Updates
7.5.6 Msn Laboratories Private Ltd Competitive Strengths & Weaknesses
7.6 Intas Pharmaceuticals Ltd
7.6.1 Intas Pharmaceuticals Ltd Details
7.6.2 Intas Pharmaceuticals Ltd Major Business
7.6.3 Intas Pharmaceuticals Ltd Imatinib Mesylate API Product and Services
7.6.4 Intas Pharmaceuticals Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Intas Pharmaceuticals Ltd Recent Developments/Updates
7.6.6 Intas Pharmaceuticals Ltd Competitive Strengths & Weaknesses
7.7 Zydus Lifesciences Ltd
7.7.1 Zydus Lifesciences Ltd Details
7.7.2 Zydus Lifesciences Ltd Major Business
7.7.3 Zydus Lifesciences Ltd Imatinib Mesylate API Product and Services
7.7.4 Zydus Lifesciences Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Zydus Lifesciences Ltd Recent Developments/Updates
7.7.6 Zydus Lifesciences Ltd Competitive Strengths & Weaknesses
7.8 Hetero Labs Ltd
7.8.1 Hetero Labs Ltd Details
7.8.2 Hetero Labs Ltd Major Business
7.8.3 Hetero Labs Ltd Imatinib Mesylate API Product and Services
7.8.4 Hetero Labs Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Hetero Labs Ltd Recent Developments/Updates
7.8.6 Hetero Labs Ltd Competitive Strengths & Weaknesses
7.9 Shilpa Pharma Lifesciences Ltd
7.9.1 Shilpa Pharma Lifesciences Ltd Details
7.9.2 Shilpa Pharma Lifesciences Ltd Major Business
7.9.3 Shilpa Pharma Lifesciences Ltd Imatinib Mesylate API Product and Services
7.9.4 Shilpa Pharma Lifesciences Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Shilpa Pharma Lifesciences Ltd Recent Developments/Updates
7.9.6 Shilpa Pharma Lifesciences Ltd Competitive Strengths & Weaknesses
7.10 Teva Pharmaceutical Industries Ltd
7.10.1 Teva Pharmaceutical Industries Ltd Details
7.10.2 Teva Pharmaceutical Industries Ltd Major Business
7.10.3 Teva Pharmaceutical Industries Ltd Imatinib Mesylate API Product and Services
7.10.4 Teva Pharmaceutical Industries Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.10.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.11 Cipla Ltd
7.11.1 Cipla Ltd Details
7.11.2 Cipla Ltd Major Business
7.11.3 Cipla Ltd Imatinib Mesylate API Product and Services
7.11.4 Cipla Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Cipla Ltd Recent Developments/Updates
7.11.6 Cipla Ltd Competitive Strengths & Weaknesses
7.12 Acebright India Pharma Private Ltd
7.12.1 Acebright India Pharma Private Ltd Details
7.12.2 Acebright India Pharma Private Ltd Major Business
7.12.3 Acebright India Pharma Private Ltd Imatinib Mesylate API Product and Services
7.12.4 Acebright India Pharma Private Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Acebright India Pharma Private Ltd Recent Developments/Updates
7.12.6 Acebright India Pharma Private Ltd Competitive Strengths & Weaknesses
7.13 Fis Fabbrica Italiana Sintetici Spa
7.13.1 Fis Fabbrica Italiana Sintetici Spa Details
7.13.2 Fis Fabbrica Italiana Sintetici Spa Major Business
7.13.3 Fis Fabbrica Italiana Sintetici Spa Imatinib Mesylate API Product and Services
7.13.4 Fis Fabbrica Italiana Sintetici Spa Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Fis Fabbrica Italiana Sintetici Spa Recent Developments/Updates
7.13.6 Fis Fabbrica Italiana Sintetici Spa Competitive Strengths & Weaknesses
7.14 Dr Reddys Laboratories Ltd
7.14.1 Dr Reddys Laboratories Ltd Details
7.14.2 Dr Reddys Laboratories Ltd Major Business
7.14.3 Dr Reddys Laboratories Ltd Imatinib Mesylate API Product and Services
7.14.4 Dr Reddys Laboratories Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Dr Reddys Laboratories Ltd Recent Developments/Updates
7.14.6 Dr Reddys Laboratories Ltd Competitive Strengths & Weaknesses
7.15 Natco Pharma Ltd
7.15.1 Natco Pharma Ltd Details
7.15.2 Natco Pharma Ltd Major Business
7.15.3 Natco Pharma Ltd Imatinib Mesylate API Product and Services
7.15.4 Natco Pharma Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Natco Pharma Ltd Recent Developments/Updates
7.15.6 Natco Pharma Ltd Competitive Strengths & Weaknesses
7.16 Sun Pharmaceutical Industries Ltd
7.16.1 Sun Pharmaceutical Industries Ltd Details
7.16.2 Sun Pharmaceutical Industries Ltd Major Business
7.16.3 Sun Pharmaceutical Industries Ltd Imatinib Mesylate API Product and Services
7.16.4 Sun Pharmaceutical Industries Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
7.16.6 Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.17 Reliance Life Sciences Pvt Ltd
7.17.1 Reliance Life Sciences Pvt Ltd Details
7.17.2 Reliance Life Sciences Pvt Ltd Major Business
7.17.3 Reliance Life Sciences Pvt Ltd Imatinib Mesylate API Product and Services
7.17.4 Reliance Life Sciences Pvt Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Reliance Life Sciences Pvt Ltd Recent Developments/Updates
7.17.6 Reliance Life Sciences Pvt Ltd Competitive Strengths & Weaknesses
7.18 Zhejiang Jiuzhou Pharmaceutical Co Ltd
7.18.1 Zhejiang Jiuzhou Pharmaceutical Co Ltd Details
7.18.2 Zhejiang Jiuzhou Pharmaceutical Co Ltd Major Business
7.18.3 Zhejiang Jiuzhou Pharmaceutical Co Ltd Imatinib Mesylate API Product and Services
7.18.4 Zhejiang Jiuzhou Pharmaceutical Co Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Zhejiang Jiuzhou Pharmaceutical Co Ltd Recent Developments/Updates
7.18.6 Zhejiang Jiuzhou Pharmaceutical Co Ltd Competitive Strengths & Weaknesses
7.19 Tai Heng Industry Group Co Ltd
7.19.1 Tai Heng Industry Group Co Ltd Details
7.19.2 Tai Heng Industry Group Co Ltd Major Business
7.19.3 Tai Heng Industry Group Co Ltd Imatinib Mesylate API Product and Services
7.19.4 Tai Heng Industry Group Co Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Tai Heng Industry Group Co Ltd Recent Developments/Updates
7.19.6 Tai Heng Industry Group Co Ltd Competitive Strengths & Weaknesses
7.20 Shandong Anxin Pharmaceutical Co Ltd
7.20.1 Shandong Anxin Pharmaceutical Co Ltd Details
7.20.2 Shandong Anxin Pharmaceutical Co Ltd Major Business
7.20.3 Shandong Anxin Pharmaceutical Co Ltd Imatinib Mesylate API Product and Services
7.20.4 Shandong Anxin Pharmaceutical Co Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 Shandong Anxin Pharmaceutical Co Ltd Recent Developments/Updates
7.20.6 Shandong Anxin Pharmaceutical Co Ltd Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Imatinib Mesylate API Industry Chain
8.2 Imatinib Mesylate API Upstream Analysis
8.2.1 Imatinib Mesylate API Core Raw Materials
8.2.2 Main Manufacturers of Imatinib Mesylate API Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Imatinib Mesylate API Production Mode
8.6 Imatinib Mesylate API Procurement Model
8.7 Imatinib Mesylate API Industry Sales Model and Sales Channels
8.7.1 Imatinib Mesylate API Sales Model
8.7.2 Imatinib Mesylate API Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Imatinib Mesylate API Introduction
1.2 World Imatinib Mesylate API Supply & Forecast
1.2.1 World Imatinib Mesylate API Production Value (2018 & 2022 & 2029)
1.2.2 World Imatinib Mesylate API Production (2018-2029)
1.2.3 World Imatinib Mesylate API Pricing Trends (2018-2029)
1.3 World Imatinib Mesylate API Production by Region (Based on Production Site)
1.3.1 World Imatinib Mesylate API Production Value by Region (2018-2029)
1.3.2 World Imatinib Mesylate API Production by Region (2018-2029)
1.3.3 World Imatinib Mesylate API Average Price by Region (2018-2029)
1.3.4 North America Imatinib Mesylate API Production (2018-2029)
1.3.5 Europe Imatinib Mesylate API Production (2018-2029)
1.3.6 China Imatinib Mesylate API Production (2018-2029)
1.3.7 Japan Imatinib Mesylate API Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Imatinib Mesylate API Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Imatinib Mesylate API Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Imatinib Mesylate API Demand (2018-2029)
2.2 World Imatinib Mesylate API Consumption by Region
2.2.1 World Imatinib Mesylate API Consumption by Region (2018-2023)
2.2.2 World Imatinib Mesylate API Consumption Forecast by Region (2024-2029)
2.3 United States Imatinib Mesylate API Consumption (2018-2029)
2.4 China Imatinib Mesylate API Consumption (2018-2029)
2.5 Europe Imatinib Mesylate API Consumption (2018-2029)
2.6 Japan Imatinib Mesylate API Consumption (2018-2029)
2.7 South Korea Imatinib Mesylate API Consumption (2018-2029)
2.8 ASEAN Imatinib Mesylate API Consumption (2018-2029)
2.9 India Imatinib Mesylate API Consumption (2018-2029)
3 WORLD IMATINIB MESYLATE API MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Imatinib Mesylate API Production Value by Manufacturer (2018-2023)
3.2 World Imatinib Mesylate API Production by Manufacturer (2018-2023)
3.3 World Imatinib Mesylate API Average Price by Manufacturer (2018-2023)
3.4 Imatinib Mesylate API Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Imatinib Mesylate API Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Imatinib Mesylate API in 2022
3.5.3 Global Concentration Ratios (CR8) for Imatinib Mesylate API in 2022
3.6 Imatinib Mesylate API Market: Overall Company Footprint Analysis
3.6.1 Imatinib Mesylate API Market: Region Footprint
3.6.2 Imatinib Mesylate API Market: Company Product Type Footprint
3.6.3 Imatinib Mesylate API Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Imatinib Mesylate API Production Value Comparison
4.1.1 United States VS China: Imatinib Mesylate API Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Imatinib Mesylate API Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Imatinib Mesylate API Production Comparison
4.2.1 United States VS China: Imatinib Mesylate API Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Imatinib Mesylate API Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Imatinib Mesylate API Consumption Comparison
4.3.1 United States VS China: Imatinib Mesylate API Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Imatinib Mesylate API Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Imatinib Mesylate API Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Imatinib Mesylate API Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Imatinib Mesylate API Production Value (2018-2023)
4.4.3 United States Based Manufacturers Imatinib Mesylate API Production (2018-2023)
4.5 China Based Imatinib Mesylate API Manufacturers and Market Share
4.5.1 China Based Imatinib Mesylate API Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Imatinib Mesylate API Production Value (2018-2023)
4.5.3 China Based Manufacturers Imatinib Mesylate API Production (2018-2023)
4.6 Rest of World Based Imatinib Mesylate API Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Imatinib Mesylate API Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Imatinib Mesylate API Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Imatinib Mesylate API Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Imatinib Mesylate API Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Purity?99%
5.2.2 Purity<99%
5.3 Market Segment by Type
5.3.1 World Imatinib Mesylate API Production by Type (2018-2029)
5.3.2 World Imatinib Mesylate API Production Value by Type (2018-2029)
5.3.3 World Imatinib Mesylate API Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Imatinib Mesylate API Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Tablet
6.2.2 Capsule
6.3 Market Segment by Application
6.3.1 World Imatinib Mesylate API Production by Application (2018-2029)
6.3.2 World Imatinib Mesylate API Production Value by Application (2018-2029)
6.3.3 World Imatinib Mesylate API Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Aurobindo Pharma Ltd
7.1.1 Aurobindo Pharma Ltd Details
7.1.2 Aurobindo Pharma Ltd Major Business
7.1.3 Aurobindo Pharma Ltd Imatinib Mesylate API Product and Services
7.1.4 Aurobindo Pharma Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Aurobindo Pharma Ltd Recent Developments/Updates
7.1.6 Aurobindo Pharma Ltd Competitive Strengths & Weaknesses
7.2 Formosa Laboratories Inc
7.2.1 Formosa Laboratories Inc Details
7.2.2 Formosa Laboratories Inc Major Business
7.2.3 Formosa Laboratories Inc Imatinib Mesylate API Product and Services
7.2.4 Formosa Laboratories Inc Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Formosa Laboratories Inc Recent Developments/Updates
7.2.6 Formosa Laboratories Inc Competitive Strengths & Weaknesses
7.3 Cadila Healthcare Ltd
7.3.1 Cadila Healthcare Ltd Details
7.3.2 Cadila Healthcare Ltd Major Business
7.3.3 Cadila Healthcare Ltd Imatinib Mesylate API Product and Services
7.3.4 Cadila Healthcare Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Cadila Healthcare Ltd Recent Developments/Updates
7.3.6 Cadila Healthcare Ltd Competitive Strengths & Weaknesses
7.4 Laurus Labs Ltd
7.4.1 Laurus Labs Ltd Details
7.4.2 Laurus Labs Ltd Major Business
7.4.3 Laurus Labs Ltd Imatinib Mesylate API Product and Services
7.4.4 Laurus Labs Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Laurus Labs Ltd Recent Developments/Updates
7.4.6 Laurus Labs Ltd Competitive Strengths & Weaknesses
7.5 Msn Laboratories Private Ltd
7.5.1 Msn Laboratories Private Ltd Details
7.5.2 Msn Laboratories Private Ltd Major Business
7.5.3 Msn Laboratories Private Ltd Imatinib Mesylate API Product and Services
7.5.4 Msn Laboratories Private Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Msn Laboratories Private Ltd Recent Developments/Updates
7.5.6 Msn Laboratories Private Ltd Competitive Strengths & Weaknesses
7.6 Intas Pharmaceuticals Ltd
7.6.1 Intas Pharmaceuticals Ltd Details
7.6.2 Intas Pharmaceuticals Ltd Major Business
7.6.3 Intas Pharmaceuticals Ltd Imatinib Mesylate API Product and Services
7.6.4 Intas Pharmaceuticals Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Intas Pharmaceuticals Ltd Recent Developments/Updates
7.6.6 Intas Pharmaceuticals Ltd Competitive Strengths & Weaknesses
7.7 Zydus Lifesciences Ltd
7.7.1 Zydus Lifesciences Ltd Details
7.7.2 Zydus Lifesciences Ltd Major Business
7.7.3 Zydus Lifesciences Ltd Imatinib Mesylate API Product and Services
7.7.4 Zydus Lifesciences Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Zydus Lifesciences Ltd Recent Developments/Updates
7.7.6 Zydus Lifesciences Ltd Competitive Strengths & Weaknesses
7.8 Hetero Labs Ltd
7.8.1 Hetero Labs Ltd Details
7.8.2 Hetero Labs Ltd Major Business
7.8.3 Hetero Labs Ltd Imatinib Mesylate API Product and Services
7.8.4 Hetero Labs Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Hetero Labs Ltd Recent Developments/Updates
7.8.6 Hetero Labs Ltd Competitive Strengths & Weaknesses
7.9 Shilpa Pharma Lifesciences Ltd
7.9.1 Shilpa Pharma Lifesciences Ltd Details
7.9.2 Shilpa Pharma Lifesciences Ltd Major Business
7.9.3 Shilpa Pharma Lifesciences Ltd Imatinib Mesylate API Product and Services
7.9.4 Shilpa Pharma Lifesciences Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Shilpa Pharma Lifesciences Ltd Recent Developments/Updates
7.9.6 Shilpa Pharma Lifesciences Ltd Competitive Strengths & Weaknesses
7.10 Teva Pharmaceutical Industries Ltd
7.10.1 Teva Pharmaceutical Industries Ltd Details
7.10.2 Teva Pharmaceutical Industries Ltd Major Business
7.10.3 Teva Pharmaceutical Industries Ltd Imatinib Mesylate API Product and Services
7.10.4 Teva Pharmaceutical Industries Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.10.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.11 Cipla Ltd
7.11.1 Cipla Ltd Details
7.11.2 Cipla Ltd Major Business
7.11.3 Cipla Ltd Imatinib Mesylate API Product and Services
7.11.4 Cipla Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Cipla Ltd Recent Developments/Updates
7.11.6 Cipla Ltd Competitive Strengths & Weaknesses
7.12 Acebright India Pharma Private Ltd
7.12.1 Acebright India Pharma Private Ltd Details
7.12.2 Acebright India Pharma Private Ltd Major Business
7.12.3 Acebright India Pharma Private Ltd Imatinib Mesylate API Product and Services
7.12.4 Acebright India Pharma Private Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Acebright India Pharma Private Ltd Recent Developments/Updates
7.12.6 Acebright India Pharma Private Ltd Competitive Strengths & Weaknesses
7.13 Fis Fabbrica Italiana Sintetici Spa
7.13.1 Fis Fabbrica Italiana Sintetici Spa Details
7.13.2 Fis Fabbrica Italiana Sintetici Spa Major Business
7.13.3 Fis Fabbrica Italiana Sintetici Spa Imatinib Mesylate API Product and Services
7.13.4 Fis Fabbrica Italiana Sintetici Spa Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Fis Fabbrica Italiana Sintetici Spa Recent Developments/Updates
7.13.6 Fis Fabbrica Italiana Sintetici Spa Competitive Strengths & Weaknesses
7.14 Dr Reddys Laboratories Ltd
7.14.1 Dr Reddys Laboratories Ltd Details
7.14.2 Dr Reddys Laboratories Ltd Major Business
7.14.3 Dr Reddys Laboratories Ltd Imatinib Mesylate API Product and Services
7.14.4 Dr Reddys Laboratories Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Dr Reddys Laboratories Ltd Recent Developments/Updates
7.14.6 Dr Reddys Laboratories Ltd Competitive Strengths & Weaknesses
7.15 Natco Pharma Ltd
7.15.1 Natco Pharma Ltd Details
7.15.2 Natco Pharma Ltd Major Business
7.15.3 Natco Pharma Ltd Imatinib Mesylate API Product and Services
7.15.4 Natco Pharma Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Natco Pharma Ltd Recent Developments/Updates
7.15.6 Natco Pharma Ltd Competitive Strengths & Weaknesses
7.16 Sun Pharmaceutical Industries Ltd
7.16.1 Sun Pharmaceutical Industries Ltd Details
7.16.2 Sun Pharmaceutical Industries Ltd Major Business
7.16.3 Sun Pharmaceutical Industries Ltd Imatinib Mesylate API Product and Services
7.16.4 Sun Pharmaceutical Industries Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
7.16.6 Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.17 Reliance Life Sciences Pvt Ltd
7.17.1 Reliance Life Sciences Pvt Ltd Details
7.17.2 Reliance Life Sciences Pvt Ltd Major Business
7.17.3 Reliance Life Sciences Pvt Ltd Imatinib Mesylate API Product and Services
7.17.4 Reliance Life Sciences Pvt Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Reliance Life Sciences Pvt Ltd Recent Developments/Updates
7.17.6 Reliance Life Sciences Pvt Ltd Competitive Strengths & Weaknesses
7.18 Zhejiang Jiuzhou Pharmaceutical Co Ltd
7.18.1 Zhejiang Jiuzhou Pharmaceutical Co Ltd Details
7.18.2 Zhejiang Jiuzhou Pharmaceutical Co Ltd Major Business
7.18.3 Zhejiang Jiuzhou Pharmaceutical Co Ltd Imatinib Mesylate API Product and Services
7.18.4 Zhejiang Jiuzhou Pharmaceutical Co Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Zhejiang Jiuzhou Pharmaceutical Co Ltd Recent Developments/Updates
7.18.6 Zhejiang Jiuzhou Pharmaceutical Co Ltd Competitive Strengths & Weaknesses
7.19 Tai Heng Industry Group Co Ltd
7.19.1 Tai Heng Industry Group Co Ltd Details
7.19.2 Tai Heng Industry Group Co Ltd Major Business
7.19.3 Tai Heng Industry Group Co Ltd Imatinib Mesylate API Product and Services
7.19.4 Tai Heng Industry Group Co Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Tai Heng Industry Group Co Ltd Recent Developments/Updates
7.19.6 Tai Heng Industry Group Co Ltd Competitive Strengths & Weaknesses
7.20 Shandong Anxin Pharmaceutical Co Ltd
7.20.1 Shandong Anxin Pharmaceutical Co Ltd Details
7.20.2 Shandong Anxin Pharmaceutical Co Ltd Major Business
7.20.3 Shandong Anxin Pharmaceutical Co Ltd Imatinib Mesylate API Product and Services
7.20.4 Shandong Anxin Pharmaceutical Co Ltd Imatinib Mesylate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 Shandong Anxin Pharmaceutical Co Ltd Recent Developments/Updates
7.20.6 Shandong Anxin Pharmaceutical Co Ltd Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Imatinib Mesylate API Industry Chain
8.2 Imatinib Mesylate API Upstream Analysis
8.2.1 Imatinib Mesylate API Core Raw Materials
8.2.2 Main Manufacturers of Imatinib Mesylate API Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Imatinib Mesylate API Production Mode
8.6 Imatinib Mesylate API Procurement Model
8.7 Imatinib Mesylate API Industry Sales Model and Sales Channels
8.7.1 Imatinib Mesylate API Sales Model
8.7.2 Imatinib Mesylate API Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Imatinib Mesylate API Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Imatinib Mesylate API Production Value by Region (2018-2023) & (USD Million)
Table 3. World Imatinib Mesylate API Production Value by Region (2024-2029) & (USD Million)
Table 4. World Imatinib Mesylate API Production Value Market Share by Region (2018-2023)
Table 5. World Imatinib Mesylate API Production Value Market Share by Region (2024-2029)
Table 6. World Imatinib Mesylate API Production by Region (2018-2023) & (Tons)
Table 7. World Imatinib Mesylate API Production by Region (2024-2029) & (Tons)
Table 8. World Imatinib Mesylate API Production Market Share by Region (2018-2023)
Table 9. World Imatinib Mesylate API Production Market Share by Region (2024-2029)
Table 10. World Imatinib Mesylate API Average Price by Region (2018-2023) & (US$/Ton)
Table 11. World Imatinib Mesylate API Average Price by Region (2024-2029) & (US$/Ton)
Table 12. Imatinib Mesylate API Major Market Trends
Table 13. World Imatinib Mesylate API Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Tons)
Table 14. World Imatinib Mesylate API Consumption by Region (2018-2023) & (Tons)
Table 15. World Imatinib Mesylate API Consumption Forecast by Region (2024-2029) & (Tons)
Table 16. World Imatinib Mesylate API Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Imatinib Mesylate API Producers in 2022
Table 18. World Imatinib Mesylate API Production by Manufacturer (2018-2023) & (Tons)
Table 19. Production Market Share of Key Imatinib Mesylate API Producers in 2022
Table 20. World Imatinib Mesylate API Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 21. Global Imatinib Mesylate API Company Evaluation Quadrant
Table 22. World Imatinib Mesylate API Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Imatinib Mesylate API Production Site of Key Manufacturer
Table 24. Imatinib Mesylate API Market: Company Product Type Footprint
Table 25. Imatinib Mesylate API Market: Company Product Application Footprint
Table 26. Imatinib Mesylate API Competitive Factors
Table 27. Imatinib Mesylate API New Entrant and Capacity Expansion Plans
Table 28. Imatinib Mesylate API Mergers & Acquisitions Activity
Table 29. United States VS China Imatinib Mesylate API Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Imatinib Mesylate API Production Comparison, (2018 & 2022 & 2029) & (Tons)
Table 31. United States VS China Imatinib Mesylate API Consumption Comparison, (2018 & 2022 & 2029) & (Tons)
Table 32. United States Based Imatinib Mesylate API Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Imatinib Mesylate API Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Imatinib Mesylate API Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Imatinib Mesylate API Production (2018-2023) & (Tons)
Table 36. United States Based Manufacturers Imatinib Mesylate API Production Market Share (2018-2023)
Table 37. China Based Imatinib Mesylate API Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Imatinib Mesylate API Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Imatinib Mesylate API Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Imatinib Mesylate API Production (2018-2023) & (Tons)
Table 41. China Based Manufacturers Imatinib Mesylate API Production Market Share (2018-2023)
Table 42. Rest of World Based Imatinib Mesylate API Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Imatinib Mesylate API Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Imatinib Mesylate API Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Imatinib Mesylate API Production (2018-2023) & (Tons)
Table 46. Rest of World Based Manufacturers Imatinib Mesylate API Production Market Share (2018-2023)
Table 47. World Imatinib Mesylate API Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Imatinib Mesylate API Production by Type (2018-2023) & (Tons)
Table 49. World Imatinib Mesylate API Production by Type (2024-2029) & (Tons)
Table 50. World Imatinib Mesylate API Production Value by Type (2018-2023) & (USD Million)
Table 51. World Imatinib Mesylate API Production Value by Type (2024-2029) & (USD Million)
Table 52. World Imatinib Mesylate API Average Price by Type (2018-2023) & (US$/Ton)
Table 53. World Imatinib Mesylate API Average Price by Type (2024-2029) & (US$/Ton)
Table 54. World Imatinib Mesylate API Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Imatinib Mesylate API Production by Application (2018-2023) & (Tons)
Table 56. World Imatinib Mesylate API Production by Application (2024-2029) & (Tons)
Table 57. World Imatinib Mesylate API Production Value by Application (2018-2023) & (USD Million)
Table 58. World Imatinib Mesylate API Production Value by Application (2024-2029) & (USD Million)
Table 59. World Imatinib Mesylate API Average Price by Application (2018-2023) & (US$/Ton)
Table 60. World Imatinib Mesylate API Average Price by Application (2024-2029) & (US$/Ton)
Table 61. Aurobindo Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 62. Aurobindo Pharma Ltd Major Business
Table 63. Aurobindo Pharma Ltd Imatinib Mesylate API Product and Services
Table 64. Aurobindo Pharma Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Aurobindo Pharma Ltd Recent Developments/Updates
Table 66. Aurobindo Pharma Ltd Competitive Strengths & Weaknesses
Table 67. Formosa Laboratories Inc Basic Information, Manufacturing Base and Competitors
Table 68. Formosa Laboratories Inc Major Business
Table 69. Formosa Laboratories Inc Imatinib Mesylate API Product and Services
Table 70. Formosa Laboratories Inc Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Formosa Laboratories Inc Recent Developments/Updates
Table 72. Formosa Laboratories Inc Competitive Strengths & Weaknesses
Table 73. Cadila Healthcare Ltd Basic Information, Manufacturing Base and Competitors
Table 74. Cadila Healthcare Ltd Major Business
Table 75. Cadila Healthcare Ltd Imatinib Mesylate API Product and Services
Table 76. Cadila Healthcare Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Cadila Healthcare Ltd Recent Developments/Updates
Table 78. Cadila Healthcare Ltd Competitive Strengths & Weaknesses
Table 79. Laurus Labs Ltd Basic Information, Manufacturing Base and Competitors
Table 80. Laurus Labs Ltd Major Business
Table 81. Laurus Labs Ltd Imatinib Mesylate API Product and Services
Table 82. Laurus Labs Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Laurus Labs Ltd Recent Developments/Updates
Table 84. Laurus Labs Ltd Competitive Strengths & Weaknesses
Table 85. Msn Laboratories Private Ltd Basic Information, Manufacturing Base and Competitors
Table 86. Msn Laboratories Private Ltd Major Business
Table 87. Msn Laboratories Private Ltd Imatinib Mesylate API Product and Services
Table 88. Msn Laboratories Private Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Msn Laboratories Private Ltd Recent Developments/Updates
Table 90. Msn Laboratories Private Ltd Competitive Strengths & Weaknesses
Table 91. Intas Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table 92. Intas Pharmaceuticals Ltd Major Business
Table 93. Intas Pharmaceuticals Ltd Imatinib Mesylate API Product and Services
Table 94. Intas Pharmaceuticals Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Intas Pharmaceuticals Ltd Recent Developments/Updates
Table 96. Intas Pharmaceuticals Ltd Competitive Strengths & Weaknesses
Table 97. Zydus Lifesciences Ltd Basic Information, Manufacturing Base and Competitors
Table 98. Zydus Lifesciences Ltd Major Business
Table 99. Zydus Lifesciences Ltd Imatinib Mesylate API Product and Services
Table 100. Zydus Lifesciences Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Zydus Lifesciences Ltd Recent Developments/Updates
Table 102. Zydus Lifesciences Ltd Competitive Strengths & Weaknesses
Table 103. Hetero Labs Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Hetero Labs Ltd Major Business
Table 105. Hetero Labs Ltd Imatinib Mesylate API Product and Services
Table 106. Hetero Labs Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Hetero Labs Ltd Recent Developments/Updates
Table 108. Hetero Labs Ltd Competitive Strengths & Weaknesses
Table 109. Shilpa Pharma Lifesciences Ltd Basic Information, Manufacturing Base and Competitors
Table 110. Shilpa Pharma Lifesciences Ltd Major Business
Table 111. Shilpa Pharma Lifesciences Ltd Imatinib Mesylate API Product and Services
Table 112. Shilpa Pharma Lifesciences Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Shilpa Pharma Lifesciences Ltd Recent Developments/Updates
Table 114. Shilpa Pharma Lifesciences Ltd Competitive Strengths & Weaknesses
Table 115. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 116. Teva Pharmaceutical Industries Ltd Major Business
Table 117. Teva Pharmaceutical Industries Ltd Imatinib Mesylate API Product and Services
Table 118. Teva Pharmaceutical Industries Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 120. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 121. Cipla Ltd Basic Information, Manufacturing Base and Competitors
Table 122. Cipla Ltd Major Business
Table 123. Cipla Ltd Imatinib Mesylate API Product and Services
Table 124. Cipla Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Cipla Ltd Recent Developments/Updates
Table 126. Cipla Ltd Competitive Strengths & Weaknesses
Table 127. Acebright India Pharma Private Ltd Basic Information, Manufacturing Base and Competitors
Table 128. Acebright India Pharma Private Ltd Major Business
Table 129. Acebright India Pharma Private Ltd Imatinib Mesylate API Product and Services
Table 130. Acebright India Pharma Private Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Acebright India Pharma Private Ltd Recent Developments/Updates
Table 132. Acebright India Pharma Private Ltd Competitive Strengths & Weaknesses
Table 133. Fis Fabbrica Italiana Sintetici Spa Basic Information, Manufacturing Base and Competitors
Table 134. Fis Fabbrica Italiana Sintetici Spa Major Business
Table 135. Fis Fabbrica Italiana Sintetici Spa Imatinib Mesylate API Product and Services
Table 136. Fis Fabbrica Italiana Sintetici Spa Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Fis Fabbrica Italiana Sintetici Spa Recent Developments/Updates
Table 138. Fis Fabbrica Italiana Sintetici Spa Competitive Strengths & Weaknesses
Table 139. Dr Reddys Laboratories Ltd Basic Information, Manufacturing Base and Competitors
Table 140. Dr Reddys Laboratories Ltd Major Business
Table 141. Dr Reddys Laboratories Ltd Imatinib Mesylate API Product and Services
Table 142. Dr Reddys Laboratories Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Dr Reddys Laboratories Ltd Recent Developments/Updates
Table 144. Dr Reddys Laboratories Ltd Competitive Strengths & Weaknesses
Table 145. Natco Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 146. Natco Pharma Ltd Major Business
Table 147. Natco Pharma Ltd Imatinib Mesylate API Product and Services
Table 148. Natco Pharma Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Natco Pharma Ltd Recent Developments/Updates
Table 150. Natco Pharma Ltd Competitive Strengths & Weaknesses
Table 151. Sun Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 152. Sun Pharmaceutical Industries Ltd Major Business
Table 153. Sun Pharmaceutical Industries Ltd Imatinib Mesylate API Product and Services
Table 154. Sun Pharmaceutical Industries Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 156. Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 157. Reliance Life Sciences Pvt Ltd Basic Information, Manufacturing Base and Competitors
Table 158. Reliance Life Sciences Pvt Ltd Major Business
Table 159. Reliance Life Sciences Pvt Ltd Imatinib Mesylate API Product and Services
Table 160. Reliance Life Sciences Pvt Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Reliance Life Sciences Pvt Ltd Recent Developments/Updates
Table 162. Reliance Life Sciences Pvt Ltd Competitive Strengths & Weaknesses
Table 163. Zhejiang Jiuzhou Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 164. Zhejiang Jiuzhou Pharmaceutical Co Ltd Major Business
Table 165. Zhejiang Jiuzhou Pharmaceutical Co Ltd Imatinib Mesylate API Product and Services
Table 166. Zhejiang Jiuzhou Pharmaceutical Co Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Zhejiang Jiuzhou Pharmaceutical Co Ltd Recent Developments/Updates
Table 168. Zhejiang Jiuzhou Pharmaceutical Co Ltd Competitive Strengths & Weaknesses
Table 169. Tai Heng Industry Group Co Ltd Basic Information, Manufacturing Base and Competitors
Table 170. Tai Heng Industry Group Co Ltd Major Business
Table 171. Tai Heng Industry Group Co Ltd Imatinib Mesylate API Product and Services
Table 172. Tai Heng Industry Group Co Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Tai Heng Industry Group Co Ltd Recent Developments/Updates
Table 174. Shandong Anxin Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 175. Shandong Anxin Pharmaceutical Co Ltd Major Business
Table 176. Shandong Anxin Pharmaceutical Co Ltd Imatinib Mesylate API Product and Services
Table 177. Shandong Anxin Pharmaceutical Co Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 178. Global Key Players of Imatinib Mesylate API Upstream (Raw Materials)
Table 179. Imatinib Mesylate API Typical Customers
Table 180. Imatinib Mesylate API Typical Distributors
Table 1. World Imatinib Mesylate API Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Imatinib Mesylate API Production Value by Region (2018-2023) & (USD Million)
Table 3. World Imatinib Mesylate API Production Value by Region (2024-2029) & (USD Million)
Table 4. World Imatinib Mesylate API Production Value Market Share by Region (2018-2023)
Table 5. World Imatinib Mesylate API Production Value Market Share by Region (2024-2029)
Table 6. World Imatinib Mesylate API Production by Region (2018-2023) & (Tons)
Table 7. World Imatinib Mesylate API Production by Region (2024-2029) & (Tons)
Table 8. World Imatinib Mesylate API Production Market Share by Region (2018-2023)
Table 9. World Imatinib Mesylate API Production Market Share by Region (2024-2029)
Table 10. World Imatinib Mesylate API Average Price by Region (2018-2023) & (US$/Ton)
Table 11. World Imatinib Mesylate API Average Price by Region (2024-2029) & (US$/Ton)
Table 12. Imatinib Mesylate API Major Market Trends
Table 13. World Imatinib Mesylate API Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Tons)
Table 14. World Imatinib Mesylate API Consumption by Region (2018-2023) & (Tons)
Table 15. World Imatinib Mesylate API Consumption Forecast by Region (2024-2029) & (Tons)
Table 16. World Imatinib Mesylate API Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Imatinib Mesylate API Producers in 2022
Table 18. World Imatinib Mesylate API Production by Manufacturer (2018-2023) & (Tons)
Table 19. Production Market Share of Key Imatinib Mesylate API Producers in 2022
Table 20. World Imatinib Mesylate API Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 21. Global Imatinib Mesylate API Company Evaluation Quadrant
Table 22. World Imatinib Mesylate API Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Imatinib Mesylate API Production Site of Key Manufacturer
Table 24. Imatinib Mesylate API Market: Company Product Type Footprint
Table 25. Imatinib Mesylate API Market: Company Product Application Footprint
Table 26. Imatinib Mesylate API Competitive Factors
Table 27. Imatinib Mesylate API New Entrant and Capacity Expansion Plans
Table 28. Imatinib Mesylate API Mergers & Acquisitions Activity
Table 29. United States VS China Imatinib Mesylate API Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Imatinib Mesylate API Production Comparison, (2018 & 2022 & 2029) & (Tons)
Table 31. United States VS China Imatinib Mesylate API Consumption Comparison, (2018 & 2022 & 2029) & (Tons)
Table 32. United States Based Imatinib Mesylate API Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Imatinib Mesylate API Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Imatinib Mesylate API Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Imatinib Mesylate API Production (2018-2023) & (Tons)
Table 36. United States Based Manufacturers Imatinib Mesylate API Production Market Share (2018-2023)
Table 37. China Based Imatinib Mesylate API Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Imatinib Mesylate API Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Imatinib Mesylate API Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Imatinib Mesylate API Production (2018-2023) & (Tons)
Table 41. China Based Manufacturers Imatinib Mesylate API Production Market Share (2018-2023)
Table 42. Rest of World Based Imatinib Mesylate API Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Imatinib Mesylate API Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Imatinib Mesylate API Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Imatinib Mesylate API Production (2018-2023) & (Tons)
Table 46. Rest of World Based Manufacturers Imatinib Mesylate API Production Market Share (2018-2023)
Table 47. World Imatinib Mesylate API Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Imatinib Mesylate API Production by Type (2018-2023) & (Tons)
Table 49. World Imatinib Mesylate API Production by Type (2024-2029) & (Tons)
Table 50. World Imatinib Mesylate API Production Value by Type (2018-2023) & (USD Million)
Table 51. World Imatinib Mesylate API Production Value by Type (2024-2029) & (USD Million)
Table 52. World Imatinib Mesylate API Average Price by Type (2018-2023) & (US$/Ton)
Table 53. World Imatinib Mesylate API Average Price by Type (2024-2029) & (US$/Ton)
Table 54. World Imatinib Mesylate API Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Imatinib Mesylate API Production by Application (2018-2023) & (Tons)
Table 56. World Imatinib Mesylate API Production by Application (2024-2029) & (Tons)
Table 57. World Imatinib Mesylate API Production Value by Application (2018-2023) & (USD Million)
Table 58. World Imatinib Mesylate API Production Value by Application (2024-2029) & (USD Million)
Table 59. World Imatinib Mesylate API Average Price by Application (2018-2023) & (US$/Ton)
Table 60. World Imatinib Mesylate API Average Price by Application (2024-2029) & (US$/Ton)
Table 61. Aurobindo Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 62. Aurobindo Pharma Ltd Major Business
Table 63. Aurobindo Pharma Ltd Imatinib Mesylate API Product and Services
Table 64. Aurobindo Pharma Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Aurobindo Pharma Ltd Recent Developments/Updates
Table 66. Aurobindo Pharma Ltd Competitive Strengths & Weaknesses
Table 67. Formosa Laboratories Inc Basic Information, Manufacturing Base and Competitors
Table 68. Formosa Laboratories Inc Major Business
Table 69. Formosa Laboratories Inc Imatinib Mesylate API Product and Services
Table 70. Formosa Laboratories Inc Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Formosa Laboratories Inc Recent Developments/Updates
Table 72. Formosa Laboratories Inc Competitive Strengths & Weaknesses
Table 73. Cadila Healthcare Ltd Basic Information, Manufacturing Base and Competitors
Table 74. Cadila Healthcare Ltd Major Business
Table 75. Cadila Healthcare Ltd Imatinib Mesylate API Product and Services
Table 76. Cadila Healthcare Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Cadila Healthcare Ltd Recent Developments/Updates
Table 78. Cadila Healthcare Ltd Competitive Strengths & Weaknesses
Table 79. Laurus Labs Ltd Basic Information, Manufacturing Base and Competitors
Table 80. Laurus Labs Ltd Major Business
Table 81. Laurus Labs Ltd Imatinib Mesylate API Product and Services
Table 82. Laurus Labs Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Laurus Labs Ltd Recent Developments/Updates
Table 84. Laurus Labs Ltd Competitive Strengths & Weaknesses
Table 85. Msn Laboratories Private Ltd Basic Information, Manufacturing Base and Competitors
Table 86. Msn Laboratories Private Ltd Major Business
Table 87. Msn Laboratories Private Ltd Imatinib Mesylate API Product and Services
Table 88. Msn Laboratories Private Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Msn Laboratories Private Ltd Recent Developments/Updates
Table 90. Msn Laboratories Private Ltd Competitive Strengths & Weaknesses
Table 91. Intas Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table 92. Intas Pharmaceuticals Ltd Major Business
Table 93. Intas Pharmaceuticals Ltd Imatinib Mesylate API Product and Services
Table 94. Intas Pharmaceuticals Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Intas Pharmaceuticals Ltd Recent Developments/Updates
Table 96. Intas Pharmaceuticals Ltd Competitive Strengths & Weaknesses
Table 97. Zydus Lifesciences Ltd Basic Information, Manufacturing Base and Competitors
Table 98. Zydus Lifesciences Ltd Major Business
Table 99. Zydus Lifesciences Ltd Imatinib Mesylate API Product and Services
Table 100. Zydus Lifesciences Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Zydus Lifesciences Ltd Recent Developments/Updates
Table 102. Zydus Lifesciences Ltd Competitive Strengths & Weaknesses
Table 103. Hetero Labs Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Hetero Labs Ltd Major Business
Table 105. Hetero Labs Ltd Imatinib Mesylate API Product and Services
Table 106. Hetero Labs Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Hetero Labs Ltd Recent Developments/Updates
Table 108. Hetero Labs Ltd Competitive Strengths & Weaknesses
Table 109. Shilpa Pharma Lifesciences Ltd Basic Information, Manufacturing Base and Competitors
Table 110. Shilpa Pharma Lifesciences Ltd Major Business
Table 111. Shilpa Pharma Lifesciences Ltd Imatinib Mesylate API Product and Services
Table 112. Shilpa Pharma Lifesciences Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Shilpa Pharma Lifesciences Ltd Recent Developments/Updates
Table 114. Shilpa Pharma Lifesciences Ltd Competitive Strengths & Weaknesses
Table 115. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 116. Teva Pharmaceutical Industries Ltd Major Business
Table 117. Teva Pharmaceutical Industries Ltd Imatinib Mesylate API Product and Services
Table 118. Teva Pharmaceutical Industries Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 120. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 121. Cipla Ltd Basic Information, Manufacturing Base and Competitors
Table 122. Cipla Ltd Major Business
Table 123. Cipla Ltd Imatinib Mesylate API Product and Services
Table 124. Cipla Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Cipla Ltd Recent Developments/Updates
Table 126. Cipla Ltd Competitive Strengths & Weaknesses
Table 127. Acebright India Pharma Private Ltd Basic Information, Manufacturing Base and Competitors
Table 128. Acebright India Pharma Private Ltd Major Business
Table 129. Acebright India Pharma Private Ltd Imatinib Mesylate API Product and Services
Table 130. Acebright India Pharma Private Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Acebright India Pharma Private Ltd Recent Developments/Updates
Table 132. Acebright India Pharma Private Ltd Competitive Strengths & Weaknesses
Table 133. Fis Fabbrica Italiana Sintetici Spa Basic Information, Manufacturing Base and Competitors
Table 134. Fis Fabbrica Italiana Sintetici Spa Major Business
Table 135. Fis Fabbrica Italiana Sintetici Spa Imatinib Mesylate API Product and Services
Table 136. Fis Fabbrica Italiana Sintetici Spa Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Fis Fabbrica Italiana Sintetici Spa Recent Developments/Updates
Table 138. Fis Fabbrica Italiana Sintetici Spa Competitive Strengths & Weaknesses
Table 139. Dr Reddys Laboratories Ltd Basic Information, Manufacturing Base and Competitors
Table 140. Dr Reddys Laboratories Ltd Major Business
Table 141. Dr Reddys Laboratories Ltd Imatinib Mesylate API Product and Services
Table 142. Dr Reddys Laboratories Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Dr Reddys Laboratories Ltd Recent Developments/Updates
Table 144. Dr Reddys Laboratories Ltd Competitive Strengths & Weaknesses
Table 145. Natco Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 146. Natco Pharma Ltd Major Business
Table 147. Natco Pharma Ltd Imatinib Mesylate API Product and Services
Table 148. Natco Pharma Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Natco Pharma Ltd Recent Developments/Updates
Table 150. Natco Pharma Ltd Competitive Strengths & Weaknesses
Table 151. Sun Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 152. Sun Pharmaceutical Industries Ltd Major Business
Table 153. Sun Pharmaceutical Industries Ltd Imatinib Mesylate API Product and Services
Table 154. Sun Pharmaceutical Industries Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 156. Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 157. Reliance Life Sciences Pvt Ltd Basic Information, Manufacturing Base and Competitors
Table 158. Reliance Life Sciences Pvt Ltd Major Business
Table 159. Reliance Life Sciences Pvt Ltd Imatinib Mesylate API Product and Services
Table 160. Reliance Life Sciences Pvt Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Reliance Life Sciences Pvt Ltd Recent Developments/Updates
Table 162. Reliance Life Sciences Pvt Ltd Competitive Strengths & Weaknesses
Table 163. Zhejiang Jiuzhou Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 164. Zhejiang Jiuzhou Pharmaceutical Co Ltd Major Business
Table 165. Zhejiang Jiuzhou Pharmaceutical Co Ltd Imatinib Mesylate API Product and Services
Table 166. Zhejiang Jiuzhou Pharmaceutical Co Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Zhejiang Jiuzhou Pharmaceutical Co Ltd Recent Developments/Updates
Table 168. Zhejiang Jiuzhou Pharmaceutical Co Ltd Competitive Strengths & Weaknesses
Table 169. Tai Heng Industry Group Co Ltd Basic Information, Manufacturing Base and Competitors
Table 170. Tai Heng Industry Group Co Ltd Major Business
Table 171. Tai Heng Industry Group Co Ltd Imatinib Mesylate API Product and Services
Table 172. Tai Heng Industry Group Co Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Tai Heng Industry Group Co Ltd Recent Developments/Updates
Table 174. Shandong Anxin Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 175. Shandong Anxin Pharmaceutical Co Ltd Major Business
Table 176. Shandong Anxin Pharmaceutical Co Ltd Imatinib Mesylate API Product and Services
Table 177. Shandong Anxin Pharmaceutical Co Ltd Imatinib Mesylate API Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 178. Global Key Players of Imatinib Mesylate API Upstream (Raw Materials)
Table 179. Imatinib Mesylate API Typical Customers
Table 180. Imatinib Mesylate API Typical Distributors
LIST OF FIGURES
Figure 1. Imatinib Mesylate API Picture
Figure 2. World Imatinib Mesylate API Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Imatinib Mesylate API Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Imatinib Mesylate API Production (2018-2029) & (Tons)
Figure 5. World Imatinib Mesylate API Average Price (2018-2029) & (US$/Ton)
Figure 6. World Imatinib Mesylate API Production Value Market Share by Region (2018-2029)
Figure 7. World Imatinib Mesylate API Production Market Share by Region (2018-2029)
Figure 8. North America Imatinib Mesylate API Production (2018-2029) & (Tons)
Figure 9. Europe Imatinib Mesylate API Production (2018-2029) & (Tons)
Figure 10. China Imatinib Mesylate API Production (2018-2029) & (Tons)
Figure 11. Japan Imatinib Mesylate API Production (2018-2029) & (Tons)
Figure 12. Imatinib Mesylate API Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Imatinib Mesylate API Consumption (2018-2029) & (Tons)
Figure 15. World Imatinib Mesylate API Consumption Market Share by Region (2018-2029)
Figure 16. United States Imatinib Mesylate API Consumption (2018-2029) & (Tons)
Figure 17. China Imatinib Mesylate API Consumption (2018-2029) & (Tons)
Figure 18. Europe Imatinib Mesylate API Consumption (2018-2029) & (Tons)
Figure 19. Japan Imatinib Mesylate API Consumption (2018-2029) & (Tons)
Figure 20. South Korea Imatinib Mesylate API Consumption (2018-2029) & (Tons)
Figure 21. ASEAN Imatinib Mesylate API Consumption (2018-2029) & (Tons)
Figure 22. India Imatinib Mesylate API Consumption (2018-2029) & (Tons)
Figure 23. Producer Shipments of Imatinib Mesylate API by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Imatinib Mesylate API Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Imatinib Mesylate API Markets in 2022
Figure 26. United States VS China: Imatinib Mesylate API Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Imatinib Mesylate API Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Imatinib Mesylate API Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Imatinib Mesylate API Production Market Share 2022
Figure 30. China Based Manufacturers Imatinib Mesylate API Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Imatinib Mesylate API Production Market Share 2022
Figure 32. World Imatinib Mesylate API Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Imatinib Mesylate API Production Value Market Share by Type in 2022
Figure 34. Purity?99%
Figure 35. Purity<99%
Figure 36. World Imatinib Mesylate API Production Market Share by Type (2018-2029)
Figure 37. World Imatinib Mesylate API Production Value Market Share by Type (2018-2029)
Figure 38. World Imatinib Mesylate API Average Price by Type (2018-2029) & (US$/Ton)
Figure 39. World Imatinib Mesylate API Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Imatinib Mesylate API Production Value Market Share by Application in 2022
Figure 41. Tablet
Figure 42. Capsule
Figure 43. World Imatinib Mesylate API Production Market Share by Application (2018-2029)
Figure 44. World Imatinib Mesylate API Production Value Market Share by Application (2018-2029)
Figure 45. World Imatinib Mesylate API Average Price by Application (2018-2029) & (US$/Ton)
Figure 46. Imatinib Mesylate API Industry Chain
Figure 47. Imatinib Mesylate API Procurement Model
Figure 48. Imatinib Mesylate API Sales Model
Figure 49. Imatinib Mesylate API Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Figure 1. Imatinib Mesylate API Picture
Figure 2. World Imatinib Mesylate API Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Imatinib Mesylate API Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Imatinib Mesylate API Production (2018-2029) & (Tons)
Figure 5. World Imatinib Mesylate API Average Price (2018-2029) & (US$/Ton)
Figure 6. World Imatinib Mesylate API Production Value Market Share by Region (2018-2029)
Figure 7. World Imatinib Mesylate API Production Market Share by Region (2018-2029)
Figure 8. North America Imatinib Mesylate API Production (2018-2029) & (Tons)
Figure 9. Europe Imatinib Mesylate API Production (2018-2029) & (Tons)
Figure 10. China Imatinib Mesylate API Production (2018-2029) & (Tons)
Figure 11. Japan Imatinib Mesylate API Production (2018-2029) & (Tons)
Figure 12. Imatinib Mesylate API Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Imatinib Mesylate API Consumption (2018-2029) & (Tons)
Figure 15. World Imatinib Mesylate API Consumption Market Share by Region (2018-2029)
Figure 16. United States Imatinib Mesylate API Consumption (2018-2029) & (Tons)
Figure 17. China Imatinib Mesylate API Consumption (2018-2029) & (Tons)
Figure 18. Europe Imatinib Mesylate API Consumption (2018-2029) & (Tons)
Figure 19. Japan Imatinib Mesylate API Consumption (2018-2029) & (Tons)
Figure 20. South Korea Imatinib Mesylate API Consumption (2018-2029) & (Tons)
Figure 21. ASEAN Imatinib Mesylate API Consumption (2018-2029) & (Tons)
Figure 22. India Imatinib Mesylate API Consumption (2018-2029) & (Tons)
Figure 23. Producer Shipments of Imatinib Mesylate API by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Imatinib Mesylate API Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Imatinib Mesylate API Markets in 2022
Figure 26. United States VS China: Imatinib Mesylate API Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Imatinib Mesylate API Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Imatinib Mesylate API Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Imatinib Mesylate API Production Market Share 2022
Figure 30. China Based Manufacturers Imatinib Mesylate API Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Imatinib Mesylate API Production Market Share 2022
Figure 32. World Imatinib Mesylate API Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Imatinib Mesylate API Production Value Market Share by Type in 2022
Figure 34. Purity?99%
Figure 35. Purity<99%
Figure 36. World Imatinib Mesylate API Production Market Share by Type (2018-2029)
Figure 37. World Imatinib Mesylate API Production Value Market Share by Type (2018-2029)
Figure 38. World Imatinib Mesylate API Average Price by Type (2018-2029) & (US$/Ton)
Figure 39. World Imatinib Mesylate API Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Imatinib Mesylate API Production Value Market Share by Application in 2022
Figure 41. Tablet
Figure 42. Capsule
Figure 43. World Imatinib Mesylate API Production Market Share by Application (2018-2029)
Figure 44. World Imatinib Mesylate API Production Value Market Share by Application (2018-2029)
Figure 45. World Imatinib Mesylate API Average Price by Application (2018-2029) & (US$/Ton)
Figure 46. Imatinib Mesylate API Industry Chain
Figure 47. Imatinib Mesylate API Procurement Model
Figure 48. Imatinib Mesylate API Sales Model
Figure 49. Imatinib Mesylate API Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
